Comparison of the protective effect of human respiratory syncytial virus Pre-F protein combined with different adjuvants in BALB/c mice

• by Mengxuan Chu, Liang Du, Hongqiao Hu, Lei Cao, Li Zhang, Naiying Mao, Zhen Zhu, Yan Zhang, Hai Li

• July 20, 2026

Incidence of Recurrent Invasive Pneumococcal Disease in Canada

• by Leah J. Ricketson, Altynay Shigayeva, Irina Rajakumar, Zoe Zhong, Kazi Hassan, Irene Martin, Alyssa Golden, Allison J. McGeer, James D. Kellner, Calgary Area Epidemiology Research Group and the Toronto Invasive Bacterial Diseases Network, Chingiz Amirov, Neil Rau, Danny Chen, Jeff Powis, Amna Faheem, Kevin Katz, Valerie Sales, Samir Patel, Abdelbaset Belhaj, Reena Lovinsky, David Rose, Christie Vermeiren, Tony Mazzulli, Jennie Johnstone, Karen Green, Michael Lingley, Andrew Simor, Samira Mubareka, Sigmund Krajden, Larissa Matukas, Sharon Walmsley, Medina Saffie, Daniel Ricciuto, Krystyna Ostrowska, David Richardson, Shannon N Pyra, Joslyn D Gray

• July 7, 2026

FDA Expands CAPVAXIVE Pediatric Use

Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.

• by Kathryn Wighton

• June 18, 2026

• 2 min

ACOG Releases 2026 Maternal Immunization Schedule

Thirteen other organizations endorsed guidance that extends across pregnancy, postpartum care, and lactation.

• by Kerri Miller

• June 12, 2026

• 3 min